Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (271-280 of 333) with videos related to

Pageof 34
Sort By:
The New England Journal of Medicine|January 25, 1973
Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemiaJ U Gutterman, R D Rossen, W T Butler, et al.
Blood|July 1, 1988
Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, S Buescher, A LeMaistre, et al.
Cancer|April 15, 1981
Prolonged remissions in adults with acute leukemia following late intensification chemotherapy and immunotherapyG P Bodey, E J Freireich, K B McCredie, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1978
Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding testsR D Rossen, R H Zubler, N K Day, et al.
Experimental Hematology|August 1, 1992
The effect of granulocyte-macrophage colony-stimulating factor on undifferentiated and mature acute myelogenous leukemia blast progenitorsZ Estrov, C H Park, C L Reading, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1988
Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapyM Shtalrid, M Talpaz, M Blick, et al.
Cancer Clinical Trials|January 1, 1980
Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanomaS S Legha, S W Hall, K C Powell, et al.
Transactions of the Association of American Physicians|January 1, 1974
New progressive factors affecting response and survival in adult acute leukemiaE J Freireich, E A Gehan, G P Bodey, et al.
Transplantation|September 1, 1973
Lymphoma-associated and HL-A antigens in the mixed leukocyte reactivity between identical siblingsG M Mavligit, J U Gutterman, E M Hersh, et al.
The New England Journal of Medicine|September 19, 1974
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérinJ U Gutterman, G Mavligit, J A Gottlieb, et al.
Pageof 34

Showing results (271-280 of 333) with videos related to

Sort By:
Pageof 34
The New England Journal of Medicine|January 25, 1973
Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemiaJ U Gutterman, R D Rossen, W T Butler, et al.
Blood|July 1, 1988
Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, S Buescher, A LeMaistre, et al.
Cancer|April 15, 1981
Prolonged remissions in adults with acute leukemia following late intensification chemotherapy and immunotherapyG P Bodey, E J Freireich, K B McCredie, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1978
Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding testsR D Rossen, R H Zubler, N K Day, et al.
Experimental Hematology|August 1, 1992
The effect of granulocyte-macrophage colony-stimulating factor on undifferentiated and mature acute myelogenous leukemia blast progenitorsZ Estrov, C H Park, C L Reading, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1988
Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapyM Shtalrid, M Talpaz, M Blick, et al.
Cancer Clinical Trials|January 1, 1980
Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanomaS S Legha, S W Hall, K C Powell, et al.
Transactions of the Association of American Physicians|January 1, 1974
New progressive factors affecting response and survival in adult acute leukemiaE J Freireich, E A Gehan, G P Bodey, et al.
Transplantation|September 1, 1973
Lymphoma-associated and HL-A antigens in the mixed leukocyte reactivity between identical siblingsG M Mavligit, J U Gutterman, E M Hersh, et al.
The New England Journal of Medicine|September 19, 1974
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérinJ U Gutterman, G Mavligit, J A Gottlieb, et al.
Pageof 34